STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52

Shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.52 and traded as high as $0.59. STRATA Skin Sciences shares last traded at $0.53, with a volume of 9,773 shares changing hands.

STRATA Skin Sciences Price Performance

The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.06 and a current ratio of 1.28. The company has a market cap of $18.58 million, a PE ratio of -1.71 and a beta of 1.58. The company’s 50-day simple moving average is $0.50 and its 200 day simple moving average is $0.52.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its quarterly earnings results on Wednesday, March 27th. The medical device company reported ($0.04) EPS for the quarter. STRATA Skin Sciences had a negative net margin of 32.47% and a negative return on equity of 52.50%. The business had revenue of $8.69 million during the quarter. On average, sell-side analysts predict that STRATA Skin Sciences, Inc. will post -0.19 earnings per share for the current fiscal year.

Hedge Funds Weigh In On STRATA Skin Sciences

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Azzad Asset Management Inc. ADV raised its holdings in shares of STRATA Skin Sciences by 289.5% in the 1st quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 49,800 shares in the last quarter. Chicago Partners Investment Group LLC raised its holdings in shares of STRATA Skin Sciences by 162.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after purchasing an additional 39,706 shares in the last quarter. Finally, 22NW LP raised its holdings in shares of STRATA Skin Sciences by 56.1% in the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock valued at $3,195,000 after purchasing an additional 1,930,693 shares in the last quarter. Hedge funds and other institutional investors own 32.43% of the company’s stock.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.